Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

MLA

Anaïs, Corma-Gómez, et al. “Severe Immunosuppression Is Related to Poorer Immunogenicity to SARS-CoV-2 Vaccines among People Living with HIV.” Clinical Microbiology and Infection, vol. 28, Nov. 2022, pp. 1492–98. EBSCOhost, https://doi.org/10.1016/j.cmi.2022.05.018.

APA

Anaïs, C.-G., Marta, F.-F., Estefanía, G., Ana, F.-L., Cristina, G.-A., Antonio, R.-J., Carmen, D., Marta, S., Laura, V., Rosario, P., Luis M, R., Antonio, R., Juan, M., Juan A, P., & Federico, G. (2022). Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV. Clinical Microbiology and Infection, 28, 1492–1498. https://doi.org/10.1016/j.cmi.2022.05.018

Chicago

Anaïs, Corma-Gómez, Fernández-Fuertes Marta, García Estefanía, Fuentes-López Ana, Gómez-Ayerbe Cristina, Rivero-Juárez Antonio, Domínguez Carmen, et al. 2022. “Severe Immunosuppression Is Related to Poorer Immunogenicity to SARS-CoV-2 Vaccines among People Living with HIV.” Clinical Microbiology and Infection 28 (November): 1492–98. doi:10.1016/j.cmi.2022.05.018.